CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis

Cancer Cell

Volumn 25, Issue 1, 2014, Pages 21-36

  Wang, Lu ^a   Zhao, Zibo ^a   Meyer, MarkB ^b   Saha, Sandeep ^c   Yu, Menggang ^c   Guo, Ailan ^d   Wisinski, KariB ^c   Huang, Wei ^b   Cai, Weibo ^b   Pike, J Wesley ^b   Yuan, Ming ^b,e   Ahlquist, Paul ^a,b   Xu, Wei ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d CELL SIGNALING TECHNOLOGY   (United States)

^e University of Wisconsin Madison   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COACTIVATOR ASSOCIATED ARGININE METHYLTRANSFERASE 1; MYC PROTEIN; PROTEIN ARGININE METHYLTRANSFERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BAF155; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RECURRENCE; CARCINOGENESIS; CELL MIGRATION; CELL STRUCTURE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME SUBSTRATE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOUSE; NEOPLASM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN ASSEMBLY AND DISASSEMBLY; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-ARGININE N-METHYLTRANSFERASES; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS;

EID: 84892427869     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2013.12.007     Document Type: Article

References (37)

1. Al-Dhaheri M., Wu J.C., Skliris G.P., Li J., Higashimato K., Wang Y.D., White K.P., Lambert P., Zhu Y.R., Murphy L., Xu W. CARM1is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells. Cancer Res. 2011, 71:2118-2128.
2. Andersen C.L., Christensen L.L., Thorsen K., Schepeler T., Sørensen F.B., Verspaget H.W., Simon R., Kruhøffer M., Aaltonen L.A., Laurberg S., Ørntoft T.F. Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. Br. J. Cancer 2009, 100:511-523.
3. Bedford M.T., Clarke S.G. Protein arginine methylation in mammals: who, what, and why. Mol. Cell 2009, 33:1-13.
4. Chen J., Archer T.K. Regulating SWI/SNF subunit levels via protein-protein interactions and proteasomal degradation: BAF155 and BAF170 limit expression of BAF57. Mol. Cell. Biol. 2005, 25:9016-9027.
5. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., Aswad D.W., Stallcup M.R. Regulation of transcription by a protein methyltransferase. Science 1999, 284:2174-2177.
6. Cheng D., Côté J., Shaaban S., Bedford M.T. The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. Mol. Cell 2007, 25:71-83.
7. Davis M.B., Liu X., Wang S., Reeves J., Khramtsov A., Huo D., Olopade O.I. Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity. Mol. Cancer 2013, 12:40.
8. DelBove J., Rosson G., Strobeck M., Chen J.G., Archer T.K., Wang W.D., Knudsen E.S., Weissman B.E. Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene. Epigenetics 2011, 6:1444-1453.
9. Dhar S., Vemulapalli V., Patananan A.N., Huang G.L., Di Lorenzo A., Richard S., Comb M.J., Guo A., Clarke S.G., Bedford M.T. Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs. Sci. Rep. 2013, 3:1311.
10. El Messaoudi S., Fabbrizio E., Rodriguez C., Chuchana P., Fauquier L., Cheng D.H., Theillet C., Vandel L., Bedford M.T., Sardet C. Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene. Proc. Natl. Acad. Sci. USA 2006, 103:13351-13356.
11. Euskirchen G.M., Auerbach R.K., Davidov E., Gianoulis T.A., Zhong G., Rozowsky J., Bhardwaj N., Gerstein M.B., Snyder M. Diverse roles and interactions of the SWI/SNF chromatin remodeling complex revealed using global approaches. PLoS Genet. 2011, 7:e1002008.
12. Frietze S., Lupien M., Silver P.A., Brown M. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. Cancer Res. 2008, 68:301-306.
13. Kadoch C., Hargreaves D.C., Hodges C., Elias L., Ho L., Ranish J., Crabtree G.R. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat. Genet. 2013, 45:592-601.
14. Kim J., Lee J., Yadav N., Wu Q., Carter C., Richard S., Richie E., Bedford M.T. Loss of CARM1 results in hypomethylation of thymocyte cyclic AMP-regulated phosphoprotein and deregulated early Tcell development. J.Biol. Chem. 2004, 279:25339-25344.
15. Kim D., Lee J., Cheng D., Li J., Carter C., Richie E., Bedford M.T. Enzymatic activity is required for the invivo functions of CARM1. J.Biol. Chem. 2010, 285:1147-1152.
16. Lapointe J., Li C., Higgins J.P., van de Rijn M., Bair E., Montgomery K., Ferrari M., Egevad L., Rayford W., Bergerheim U., et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl. Acad. Sci. USA 2004, 101:811-816.
17. Lee J., Bedford M.T. PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays. EMBO Rep. 2002, 3:268-273.
18. Liu P.Q., Chan E.M., Cost G.J., Zhang L., Wang J., Miller J.C., Guschin D.Y., Reik A., Holmes M.C., Mott J.E., et al. Generation of a triple-gene knockout mammalian cell line using engineered zinc-finger nucleases. Biotechnol. Bioeng. 2010, 106:97-105.
19. Mann M., Cortez V., Vadlamudi R. PELP1 oncogenic functions involve CARM1 regulation. Carcinogenesis 2013, 34:1468-1475.
20. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., Massagué J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524.
21. Park J., Wood M.A., Cole M.D. BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation. Mol. Cell. Biol. 2002, 22:1307-1316.
22. Phelan M.L., Sif S., Narlikar G.J., Kingston R.E. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol. Cell 1999, 3:247-253.
23. Roberts C.W.M., Leroux M.M., Fleming M.D., Orkin S.H. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell 2002, 2:415-425.
24. Shadeo A., Chari R., Lonergan K.M., Pusic A., Miller D., Ehlen T., Van Niekerk D., Matisic J., Richards-Kortum R., Follen M., et al. Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia. BMC Genomics 2008, 9:64.
25. Shi S.P., Qiu J.D., Sun X.Y., Suo S.B., Huang S.Y., Liang R.P. PMeS: prediction of methylation sites based on enhanced feature encoding scheme. PLoS ONE 2012, 7:e38772.
26. Tomlins S.A., Mehra R., Rhodes D.R., Cao X., Wang L., Dhanasekaran S.M., Kalyana-Sundaram S., Wei J.T., Rubin M.A., Pienta K.J., et al. Integrative molecular concept modeling of prostate cancer progression. Nat. Genet. 2007, 39:41-51.
27. Tront J.S., Huang Y., Fornace A.J., Hoffman B., Liebermann D.A. Gadd45a functions as a promoter or suppressor of breast cancer dependent on the oncogenic stress. Cancer Res. 2010, 70:9671-9681.
28. Urquidi V., Goodison S. Genomic signatures of breast cancer metastasis. Cytogenet. Genome Res. 2007, 118:116-129.
29. Varambally S., Yu J., Laxman B., Rhodes D.R., Mehra R., Tomlins S.A., Shah R.B., Chandran U., Monzon F.A., Becich M.J., et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 2005, 8:393-406.
30. Wang L., Charoensuksai P., Watson N.J., Wang X., Zhao Z., Coriano C.G., Kerr L.R., Xu W. CARM1 automethylation is controlled at the levelof alternative splicing. Nucleic Acids Res. 2013, 41:6870-6880.
31. Weissman B., Knudsen K.E. Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer. Cancer Res. 2009, 69:8223-8230.
32. Wolfer A., Wittner B.S., Irimia D., Flavin R.J., Lupien M., Gunawardane R.N., Meyer C.A., Lightcap E.S., Tamayo P., Mesirov J.P., et al. MYC regulation of a "poor-prognosis" metastatic cancer cell state. Proc. Natl. Acad. Sci. USA 2010, 107:3698-3703.
33. Wu J., Xu W. Histone H3R17me2a mark recruits human RNA polymerase-associated factor 1 complex to activate transcription. Proc. Natl. Acad. Sci. USA 2012, 109:5675-5680.
34. Yadav N., Lee J., Kim J., Shen J., Hu M.C., Aldaz C.M., Bedford M.T. Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice. Proc. Natl. Acad. Sci. USA 2003, 100:6464-6468.
35. Zabarovsky E.R., Lerman M.I., Minna J.D. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002, 21:6915-6935.
36. Zeller K.I., Zhao X., Lee C.W., Chiu K.P., Yao F., Yustein J.T., Ooi H.S., Orlov Y.L., Shahab A., Yong H.C., et al. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc. Natl. Acad. Sci. USA 2006, 103:17834-17839.
37. Zeng H., Wu J., Bedford M.T., Sbardella G., Hoffmann F.M., Bi K., Xu W. A TR-FRET-based functional assay for screening activators of CARM1. ChemBioChem 2013, 14:827-835.